Research article · 30 Jul 2026
Conference abstractPublished 29 May 2023
Effects of CTCE-9908 and MAZ-51 on the metastasis of melanoma
Northwest University, South Africa
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Melanoma is a relentless form of cancer, which predominantly spreads via the lymphatic system and accounts for 1-2% of all cancer-related mortality globally. The metastatic behaviour of these malignancies has accentuated the need for specific therapeutic targets to inhibit metastasis. Tumour cells overexpress lymphatic growth factors namely vascular endothelial growth factor C (VEGFC) and vascular endothelial growth factor-D (VEGF-D). VEGF-C and VEGF-D enhance tumour cell metastasis. VEGF-C/D binding to vascular endothelial growth factor receptor-3 (VEGFR-3) on the tumour cell. Overexpression of VEGF-C/D regulates the expression of a chemokine receptor CXCR-4 on the tumour cell. The phosphorylation of CXCR-4 to CXCL12 and VEGFR-3 to VEGF-C/D activates signalling pathways such as PI3K/AKT and MAPK that promote tumour cell proliferation and adhesion. 3-(4-Dimethylaminonaphthelen- 1-methylene)-1,3-dihydroindol-2-one (MAZ-51) inhibits phosphorylation of VEGFR-3. MAZ-51 limits proliferation and activates apoptosis in cancer cells, preventing cancer cell metastasis through the lymphatic vasculature. CTCE-9908, is a CXCR-4 antagonist which hinders CXCR-4 phosphorylation and is derived from human CXCL12. The research project entails cell culture-related laboratory experimental work on melanoma B-16F10 cell line in vitro. The work will be further translated to mouse in vivo models. Furthermore, mathematical modelling will be used to predict the effects of the compounds. Mathematical models are incorporated in this study due to the current trend in laboratorybased- research moving towards computational design based on mathematics modelling. The use of MAZ-51 and CTCE-9908 and in combination will hopefully hinder tumour metastasis and may prove to be a useful in the therapeutic approach of melanoma metastasis. Keywords:3-(4-Dimethylamino-naphthelen-1- methylene)-1,3-dihydroindol-2-one; adhesion; melanoma; endothelioma; vascular endothelial growth factor receptor-3; CXCR-4, CXCL12 and CTCE- 9908.
Subjects
DermatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical & Experimental Dermatology Research.
Commentary · 30 Jul 2026
Breaking the Stigma Around Psoriasis: A Broader View of Chronic Skin Disease
Perspective · 28 Jul 2026
Acne as More Than a Cosmetic Concern: A Personal and Medical Perspective
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Dermatology Research
- SubjectDermatology
- BylineArticles whose byline prints “Yvette Nkondo Hlophe”
